The Regulatory Map— Sorting the Pharmaceutical Affairs Act, the Advertising Standards, the MSA Guidelines, and the JPMA Code into four layers

01What a Regulatory Map Is — the Deliverable of Gate B

Recall from Issue 2 (Lifecycle Design) that we cut the whole contract workflow into 10 phases and 4 gates. Phase 3 is Gate B, the regulatory map. The deliverable here is not a design comp or a rough draft. It is a single sheet that lists, for this project, which provision of which norm bites on which medium, down to the article number.

Building the map serves two purposes. First, it gives downstream QC (Gate C) and QA (Gate D) something to check against. A review that starts with undefined check items is just a memory test of the reviewer. Second, it kills "claims you cannot make at all" upstream. Discovering a §68 violation after you have drawn a key visual hinting at a pre-approval product means the entire design fee evaporates.

02Separating the Reach of Four Layers

Stack the norms into four layers. The lower the layer, the stronger its legal force; the higher, the closer it sits to voluntary industry discipline and concrete operation. Their reach overlaps, so spell out which layer handles what.

The trick is to read "L" as an escalation order. When a claim is in doubt, test it bottom-up: first L1 "is it illegal?", then L2 "does it breach the admin standard?", then L3 "was the procedure followed?", and finally L4 "does it honor the self-rule conventions?". Stacking from the bottom kills the fatal wound (illegality) first. Consult the primary texts: the Act, Advertising Standards, MSA Guidelines, JPMA Code, and JPMA Creation Guide.

03Never Swap the Article Numbers — §66/§68/§68-2

For L1, never confuse the three articles. The most common accident on the production floor is exactly this mix-up.

04Decompose the Media — What Bites Changes by Medium

For the same product, the applicable provisions change with the medium. The map has one row per medium. Break down the media you handle most under contract.

• Product information summaries / IF: The JPMA Creation Guide (L4) governs the procedure in detail — order of items, explicit sourcing.
• MR briefing slides / detailing materials: Hits the MSA Guidelines (L3) info-provision activity directly, plus the Advertising Standards (L2).
• Web/email to HCPs: Ad-applicability judgment is key. If it qualifies, §66/L2; as an activity, L3.
• Disease awareness (public): The moment a product name or efficacy appears, it risks becoming an ad. Hinting at an unapproved indication is §68.
• Congress exhibits / sponsored content: L3 procedure + L4 conventions + conflict-of-interest disclosure.

05Regulatory Map Template (Column Definitions)

Fix the map to these columns. One spreadsheet row = one (medium × issue). Fixed columns let you fill any project with the same eye.

Do not push an issue through with the "Article/clause" cell blank and a "needs check" note. An issue with no citable basis is not reproducible in review. If you cannot cite the article, that is a sign you have not read the norm through.

06Six-Step SOP to Fill the Map

Fix the procedure as a skeleton. The point is not to skip phases; the content of each step varies by project.

1. Confirm approval status: approved / pre-approval / indication-expanding. If pre-approval, put §68 at the top and start from ad-applicability.
2. Inventory the media: lay out every deliverable. Miss one and that medium goes unmanaged.
3. Extract issues: mechanically apply the five lenses — efficacy, safety, comparison, data, testimonials — to each medium.
4. Assign norms: for each issue, test L1→L4 in order and record every layer that bites (overlap allowed).
5. Fix article numbers: L1 to the § number, L2 to the standard's clause, L3/L4 to the relevant chapter/section.
6. Verbalize the criterion: state "what makes it OK/NG" in one sentence, at a grain QC can use as-is.

If Step 4 yields an issue where no layer bites, either the issue is set too coarsely or it is out of scope. If the latter, write "N/A (reason)" and skip Step 5. Never leave a blank without a reason.

07Self-Check — Pass Conditions for a Finished Map

Gate B passes only when all of the following hold. Miss one and it goes back as incomplete.

• ☐ Every medium exists as a row; empty cells carry "N/A (reason)"
• ☐ Approval status confirmed; if pre-approval, the §68 judgment sits at the top
• ☐ Every issue ties to an article/clause; none left as "needs check"
• ☐ No §66/§68/§68-2 mix-up (pre-approval = §68, exaggeration = §66, info-provision = §68-2)
• ☐ Each issue has a one-sentence criterion QC can reference directly
• ☐ Reviewer and gate (C/D) are assigned

08Handing the Map Downstream — Converting to a QC Checklist

The map alone does not protect the asset. It only bites once converted into the next phase's (Gate C, QC) checklist. The conversion is mechanical: map row → QC item. The "criterion" column becomes the QC pass/fail condition verbatim.

This linkage is what makes possible the tracking covered in Issue 10 (Traceability (in preparation)) — which claim passed, on which provision, by whose judgment. Only because the map ties down to article numbers can you later reproduce "why was this claim OK?". A project that ran without a map cannot retrofit traceability.

Next time (Phase 4) we cross this regulatory map against the scientific-accuracy layer. Clear compliance but get the numbers wrong, and you fail at the second layer of quality. The map is the entrance, not the exit.